Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

Dal 2015-07-01 al 2018-06-30, progetto in corso

Dettagli del progetto

Costo totale:

EUR 3 893 307,50

Contributo UE:

EUR 3 583 396

Coordinato in:

United Kingdom

Invito a presentare proposte:

H2020-SMEINST-2-2014See other projects for this call

Meccanismo di finanziamento:

SME-2 - SME instrument phase 2

Obiettivo

Coordinatore

PROTEINLOGIC LIMITED
United Kingdom

Contributo UE: EUR 2 921 750


SHAKESPEARE HOUSE 42 NEWMARKET ROAD
CB5 8EP CAMBRIDGE CAMBRIDGESHIRE
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partecipanti

BIOSENSIA LIMITED
Ireland

Contributo UE: EUR 661 646


UNIT 1 16 NOVA UCD UNIVERSITY COLLEGE DUBLIN BELFIELD
4 DUBLIN
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Numero di registrazione: 197522 / Ultimo aggiornamento: 2016-01-20